Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 17, 2020
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
[ Fri, Apr 17th 2020
] - WOPRAI
Thu, April 16, 2020
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
Chris Howerton Initiated (ACAD) at Strong Buy and Held Target at $60 on, Apr 16th, 2020
Chris Howerton of Jefferies, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $60 on, Apr 16th, 2020.
Chris has made no other calls on ACAD in the last 4 months.
There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 0 agree with Chris's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Chris
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $72 on, Tuesday, March 31st, 2020
- Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $69 on, Friday, March 6th, 2020
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $75 on, Thursday, February 27th, 2020
- Yatin Suneja of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Monday, December 16th, 2019
